On CNBC's "Mad Money Lightning Round," Jim Cramer said he isn't a fan of Netflix, Inc. (NASDAQ: NFLX) because the content isn't as compelling as it once was. He sees it as a good story, but not as a great story.
Cramer is willing to recommend Cytokinetics, Inc. (NASDAQ: CYTK), but he thinks it as a very speculative stock.
Yeti Holdings Inc (NYSE: YETI) is a buying opportunity, said Cramer. He liked its earnings results.
Kraft Heinz Co (NASDAQ: KHC) has no growth, said Cramer.
Chico's FAS, Inc. (NYSE: CHS) had a horrible quarter, said Cramer. He isn't a buyer of the stock.
See more from Benzinga
- Dan Deming's Options Trade Ahead Of Netflix's Earning
- Altria, CBS, IBM, Netflix: 'Fast Money' Picks For October 5
- Todd Gordon's Bearish Netflix Options Trade
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.